Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06762925

Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment

Sponsor: Xijing Hospital

View on ClinicalTrials.gov

Summary

This study aims to validate the accuracy and clinical value of METTL3 as a biomarker for predicting immune therapy response in patients with urinary tract tumors through observational studies.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

450

Start Date

2025-01-30

Completion Date

2026-06-01

Last Updated

2025-01-08

Healthy Volunteers

No

Interventions

OTHER

No Interventions

No Interventions